White Paper: NiceLabel 21 CFR Part 11 Compliance Assessment

Drug and medical device manufacturers as well as companies in other FDA regulated industries are required to provide electronic records and signatures as a reliable equivalent to paper records. This white paper examines the FDA and EU regulatory standards and outlines how NiceLabel solutions ensure proper label life cycle compliance. You will learn how NiceLabel integrates the labeling required for life sciences regulations with customers’ existing workflows and business information systems including Oracle, SAP, or another ERP system.

White paper - FDA 21 CFR Part 11

This paper will provide companies with varying printing and administrative workflows information on the software tools they need to comply with FDA and EU regulations.

Download the White Paper 21 CFR Compliance Assessment to learn more.

Enter your information to download the White Paper